Welcome to our dedicated page for Synopsys SEC filings (Ticker: SNPS), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Synopsys, Inc. (SNPS) SEC filings page on Stock Titan provides access to the company’s regulatory disclosures as filed with the U.S. Securities and Exchange Commission. Synopsys common stock is registered on the Nasdaq Global Select Market, and the company regularly uses Form 8-K and other filings to report material events, financial results, and governance changes. These documents are central resources for understanding how Synopsys presents its business segments, strategic actions, and risk factors to investors.
Recent 8-K filings illustrate several themes that may be of interest to shareholders and analysts. One filing reports a restructuring plan approved by the board of directors, which is expected to affect approximately 10% of the workforce as of fiscal 2025 year-end. Synopsys states that this plan is intended to support investment in key growth opportunities and drive business efficiencies following the completion of its acquisition of Ansys, Inc., with substantial completion expected by the end of fiscal year 2027, subject to local requirements.
Other 8-Ks disclose topics such as the departure or appointment of certain officers, reaffirmation of financial targets, and the announcement of quarterly financial results. In its earnings-related filings and press releases, Synopsys reports revenue and net income on both GAAP and non-GAAP bases, provides reconciliations, and explains adjustments related to amortization of acquired intangible assets, stock-based compensation, acquisition and divestiture items, restructuring charges, and tax effects.
Filings also document regulatory and export control developments. For example, Synopsys reported receiving a letter from the U.S. Department of Commerce’s Bureau of Industry and Security rescinding previously imposed export restrictions related to China, and noted that it is working to restore access to affected products while assessing the impact of such restrictions on its business. Forward-looking statements sections in these filings outline risks and uncertainties related to macroeconomic conditions, industry trends, acquisitions, export controls, and other factors.
Through Stock Titan, users can review these SEC documents alongside AI-powered summaries that highlight key items such as restructuring plans, segment disclosures, export control updates, and earnings metrics. This helps readers quickly identify the portions of Synopsys’ 8-Ks, 10-Ks, 10-Qs, and related filings that are most relevant to their analysis of SNPS.
Shelagh Glaser, Chief Financial Officer of Synopsys, filed a Form 4 reporting option exercises and share transactions executed pursuant to a Rule 10b5-1 trading plan. The report shows transactions dated 09/05/2025 under a 10b5-1 plan adopted January 13, 2025. On that date Ms. Glaser acquired 2,612 shares via a $348.17-priced non-qualified option and 1,043 shares via a $354.45-priced non-qualified option. The Form also reports corresponding dispositions of 2,612 and 1,043 shares at $609.77. Beneficial ownership totals shown after the transactions include 17,929, 16,360 and 15,317 shares in various lines. The Form 4 was submitted by POA Liz Ramirez on 09/09/2025.
Form 144 notice for Synopsys, Inc. (SNPS) indicates a proposed sale of 3,655 shares of common stock through Morgan Stanley Smith Barney on 09/05/2025. The filing reports an aggregate market value of $2,228,709.35 and lists 155,160,938 shares outstanding. The securities were acquired on 09/05/2025 by stock option exercise and paid in cash on the same date. The filing also discloses a prior sale by Shelagh M Glaser of 7,310 shares on 06/06/2025 for $3,550,608.81. The form includes the seller's representation about absence of undisclosed material information.
Janet Lee, General Counsel and Corporate Secretary of Synopsys, reported transactions on 09/03/2025. The filing shows the vesting/conversion of 293 restricted stock units into common stock and related non-derivative entries. Following the reported activity, the filing lists beneficial ownership figures of 8,986 and 8,858 shares in two common-stock lines. The company retained a portion of shares to satisfy the reporting person’s tax-withholding obligations for the vested award, as disclosed by the reporting person.
Synopsys insider activity: Janet Lee, Synopsys director and GC & Corporate Secretary, received 700 restricted stock units that vested on 09/01/2025 and that will convert into 700 shares subject to a March 1, 2027 final vesting schedule with subsequent quarterly installments. To satisfy tax withholding on the vested installment, the company retained 305 shares at an average withholding value of $603.52, leaving the reporting person with 8,693 shares after the transactions. The retained shares were approved by the Compensation Committee and were not more than the reported tax liability.
Ghazi Sassine, President and CEO and a director of Synopsys, reported multiple transactions in SNPS common stock on Form 4. The filing shows acquisitions on 08/29/2025 of shares under the Employee Stock Purchase Plan and on 09/02/2025 via exercise of a non-qualified stock option for 11,366 shares at a $89.76 exercise price. The same day (09/02/2025) 11,366 shares were sold in multiple transactions at prices ranging from $585.19 to $591.265, with a weighted average sale price of $589.0133. Reported beneficial ownership levels changed from 82,981 shares after the option exercise to 71,615 shares following the sale. The trades were effected pursuant to a Rule 10b5-1 trading plan adopted September 30, 2024.
Synopsys insider purchase by CFO: This Form 4 shows Shelagh Glaser, identified as an officer (CFO) and director, acquired 26 shares of Synopsys, Inc. (SNPS) common stock on 08/29/2025 under the company's Employee Stock Purchase Plan at a price of $376.771 per share. After the transaction she beneficially owns 15,317 shares. The filing is signed by power of attorney Liz Ramirez for Shelagh Glaser on 09/03/2025. The report is filed by one reporting person and cites the ESPP as the acquisition source.
Synopsys insider purchase under ESPP: Sudhindra Kankanwadi, identified as an officer serving as Chief Accounting Officer, reported an acquisition of 26 shares of Synopsys Inc. (SNPS) common stock on 08/29/2025 under the company’s Employee Stock Purchase Plan at a reported price of $376.771 per share. After the transaction, the filing shows Mr. Kankanwadi beneficially owns 20,520 shares directly. The Form 4 was signed by a power of attorney on 09/03/2025. The filing is a routine Section 16 disclosure of an employee-plan purchase and contains no additional financial or forward-looking information.
Insider purchase filed on Form 4 for Synopsys, Inc. (SNPS). Aart de Geus, Executive Chair and Director, reported acquiring 26 shares of Synopsys common stock on 08/29/2025 at a price of $376.771 per share through the company Employee Stock Purchase Plan. After the transaction, Mr. de Geus is shown as beneficially owning 117,586 shares directly, plus 308,791 shares held indirectly by a family trust and 14,500 shares held indirectly by a partnership. The Form 4 was signed by power of attorney on 09/03/2025. The filing documents a routine ESPP purchase and updates aggregate insider holdings.
Richard S. Mahoney, Chief Revenue Officer of Synopsys, Inc. (SNPS), reported an acquisition of company common stock under the Employee Stock Purchase Plan on 08/29/2025. The form shows he purchased 26 shares at a price of $376.771 per share. After the transaction his beneficial ownership is reported as 1,511 shares, held directly. The filing was submitted via power of attorney by Liz Ramirez on 09/03/2025. No derivative transactions or additional changes are disclosed.
Synopsys Inc. (SNPS) filed a Form 144 notifying a proposed sale of 11,366 common shares via Morgan Stanley Smith Barney LLC on 09/02/2025. The filing shows an aggregate market value of $6,694,724.03 and total shares outstanding of 155,160,938. The shares were acquired the same day through a stock option exercise from the issuer, with payment made in cash. No securities sales by the reporting person were reported in the prior three months. The notice includes the standard representation that the seller is not aware of undisclosed material adverse information.